The 4G/4G plasminogen activator inhibitor-1 genotype is associated with frequent recurrence of acute otitis media

Pediatrics

Volumn 120, Issue 2, 2007, Pages

  Emonts, Marieke ^a   Wiertsema, Selma P ^b   Veenhoven, Reinier H ^c   Houwing Duistermaat, Jeanine J ^d   Walraven, Vanessa ^b   De Groot, Ronald ^e   Hermans, Peter W M ^e   Sanders, Elisabeth A M ^b  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Infection and Immunology   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Otitis media; Plasminogen activator inhibitor 1; Polymorphism

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ACUTE OTITIS MEDIA; ALLELE; ARTICLE; CHILD; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; RECURRENT INFECTION;

ACUTE DISEASE; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; MALE; OTITIS MEDIA; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECURRENCE; VARIATION (GENETICS);

EID: 34547651191     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-1390     Document Type: Article

References (39)

1. Howie VM, Ploussard JH, Sloyer J. The "otitis-prone" condition. Am J Dis Child. 1975;129:676-678
2. Alho OP, Koivu M, Sorri M. What is an "otitis-prone" child? Int J Pediatr Otorhinolaryngol. 1991;21:201-209
3. Faden H, Duffy L, Boeve M. Otitis media: back to basics. Pediatr Infect Dis J. 1998;17:1105-1113
4. Harsten G, Prellner K, Heldrup J, Kalm O, Kornfalt R. Recurrent acute otitis media. A prospective study of children during the first three years of life. Acta Otolaryngol. 1989;107:111-119
5. Froom J, Culpepper L, Green LA, et al. A cross-national study of acute otitis media: risk factors, severity, and treatment at initial visit - report from the International Primary Care Network (IPCN) and the Ambulatory Sentinel Practice Network (ASPN). J Am Board Fam Pract. 2001;14:406-417
6. Rovers MM, Schilder AG, Zielhuis GA, Rosenfeld RM. Otitis media. Lancet. 2004;363:465-473
7. Rovers MM, Zielhuis GA, Ingels K, van der Wilt GJ. Day-care and otitis media in young children: a critical overview. Eur J Pediatr. 1999;158:1-6
8. Casselbrant ML, Mandel EM, Fall PA, et al. The heritability of otitis media: a twin and triplet study. JAMA. 1999;282:2125-2130
9. Casselbrant ML, Mandel EM. Genetic susceptibility to otitis media. Curr Opin Allergy Clin Immunol. 2005;5:1-4
10. Kvaerner KJ, Tambs K, Harris JR, Magnus P. Distribution and heritability of recurrent ear infections. Ann Otol Rhinol Laryngol. 1997;106:624-632
11. Rovers M, Haggard M, Gannon M, Koeppen-Schomerus G, Plomin R. Heritability of symptom domains in otitis media: a longitudinal study of 1,373 twin pairs. Am J Epidemiol. 2002;155:958-964
12. Casselbrant ML, Mandel EM, Rockette HE, et al. The genetic component of middle ear disease in the first 5 years of life. Arch Otolaryngol Head Neck Surg. 2004;130:273-278
13. Kvestad E, Kvaerner KJ, Roysamb E, Tambs K, Harris JR, Magnus P. Otitis media: genetic factors and sex differences. Twin Res. 2004;7:239-244
14. Kohler HP, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med. 2000;342:1792-1801
15. Irigoyen JP, Munoz-Canoves P, Montero L, Koziczak M, Nagamine Y. The plasminogen activator system: biology and regulation. Cell Mol Life Sci. 1999;56:104-132
16. Kjoller L, Kanse SM, Kirkegaard T, et al. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation. Exp Cell Res. 1997;232:420-429
17. Stefansson S, Lawrence DA. The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature. 1996;383:441-443
18. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem. 1993;268:10739-10745
19. Eriksson P, Kallin B, van 't Hooft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A. 1995;92:1851-1855
20. Hermans PW, Hibberd ML, Booy R, et al. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet. 1999;354:556-560
21. Hoekstra T, Geleijnse JM, Schouten EG, Kluft C. Diurnal variation in PAI-1 activity predominantly confined to the 4G-allele of the PAI-1 gene. Thromb Haemost. 2002;88:794-798
22. Cho SH, Ryu CH, Oh CK. Plasminogen activator inhibitor-1 in the pathogenesis of asthma. Exp Biol Med (Maywood). 2004;229:138-146
23. Buckova D, Izakovicova Holla L, Vacha J. Polymorphism 4G/5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population. Allergy. 2002;57:446-448
24. Haralambous E, Hibberd M, Ninis N, Hermans P, Nadel E, Levin M. The role of the functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity and outcome of meningococcal disease in Caucasian children. Crit Care Med. 2003;31:2788-2793
25. Geishofer G, Binder A, Muller M, et al. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia. Eur J Pediatr. 2005;164:486-490
26. Veenhoven R, Bogaert D, Uiterwaal C, et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet. 2003;361:2189-2195
27. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics. 1997;53:1253-1261
28. Cubellis MV, Andreasen P, Ragno P, Mayer M, Dano K, Blasi F. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor. Proc Natl Acad Sci U S A. 1989;86:4828-4832
29. Stephens RW, Pollanen J, Tapiovaara H, et al. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J Cell Biol. 1989;108:1987-1995
30. Deng G, Curriden SA, Wang S, Rosenberg S, Loskutoff DJ. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J Cell Biol. 1996;134:1563-1571
31. Hansson A, Li J, Eriksson PO, Ny T, Berggren D, Hellström S. Tympanic membrane healing in vitro. A study in plasminogen deficient mice. In: 5th Extraordinary International Symposium on Recent Advances in Otitis Media, OM2005; April 24-27, 2005; Amsterdam, Netherlands; 2005:08.02
32. Eriksson PO, Li J, Ny T, Hellström S. Spontaneous development of chronic middle ear disease due to plasminogen deficiency. Presented at: the 5th Extraordinary International Symposium on Recent Advances in Otitis Media, OM2005; April 24-27, 2005; Amsterdam, Netherlands; 2005:16.4
33. Romer J, Lund LR, Eriksen J, et al. Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds. J Invest Dermatol. 1991;97:803-811
34. Romer J, Lund LR, Eriksen J, Pyke C, Kristensen P, Dano K. The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds. J Invest Dermatol. 1994;102:519-522
35. Romer J, Bugge TH, Pyke C, et al. Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med. 1996;2:287-292
36. Chen A, Li HS, Hebda PA, Zeevi A, Swarts JD. Gene expression profiles of early pneumococcal otitis media in the rat. Int J Pediatr Otorhinolaryngol. 2005;69:1383-1393
37. Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. Pediatr Infect Dis J. 1992;11(8 suppl):S7-S11
38. Del Beccaro MA, Mendelman PM, Inglis AF, et al. Bacteriology of acute otitis media: a new perspective. J Pediatr. 1992;120:81-84
39. Kilpi T, Herva E, Kaijalainen T, Syrjanen R, Takala AK. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J. 2001;20:654-662